This summary was created by AI, based on 1 opinions in the last 12 months.
iShares S&P Global Healthcare (XHC-T) stands out as a top contender in the healthcare sector, benefitting from a market-cap weighted structure that provides balanced exposure to leading companies within the industry. With a management expense ratio (MER) of 0.66%, investors find it a cost-effective option for gaining access to a diversified portfolio in healthcare. The fund's strategic positioning aligns well with current market trends, potentially yielding positive returns as global healthcare continues to grow. Experts generally praise its structured approach and reputable standing in the investment community, underscoring its relevance in today's dynamic market environment.
Healthcare ETF. Playing the global healthcare space. BMO has one with a currency hedge on it. Thinks Healthcare will be a good bet for the next 20-30 years. You have to look at what is in them. Pharma vs. Biotech are different stories. This one is mostly large Pharma, which has its challenges. Should be bought about $30 where there is good support.
This is a global basket of health care stocks. Chart shows a little bit of a correction that took place in the early part of the year. Had a strong run at the beginning of the year which is very unusual for healthcare. There has been a pull back which is fine because it did so well earlier on. It is now getting back close to the top. We are into the seasonal period for healthcare, which is in August. We are just a few weeks away from that so this is an attractive sector.
iShares S&P Global Healthcare is a Canadian stock, trading under the symbol XHC-T on the Toronto Stock Exchange (XHC-CT). It is usually referred to as TSX:XHC or XHC-T
In the last year, 1 stock analyst published opinions about XHC-T. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for iShares S&P Global Healthcare.
iShares S&P Global Healthcare was recommended as a Top Pick by on . Read the latest stock experts ratings for iShares S&P Global Healthcare.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered iShares S&P Global Healthcare In the last year. It is a trending stock that is worth watching.
On 2025-04-14, iShares S&P Global Healthcare (XHC-T) stock closed at a price of $63.93.
Market-cap weighted. MER is 0.66%.